# US 2016/0354405 A1 · Method to prepare ganoderma lucidum polysaccharides possessing insulin-sensitizing properties and applications thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0354405 A1
- Document ID: US20160354405A1
- Status: Published application
- Kind: A1
- Application number: 14/855,055
- Filed: 2015-09-15
- Published: 2016-12-08
- Earliest claimed: 2015-06-05
- Assignees: Chang Gung Biotechnology Corp.
- Applicants: Chang Gung Biotechnology Corp.
- Inventors: Yun-Fei Ko; Jan Martel; Jian-Ching Liau; I-Te Chang; Wei-Ting Jian; Mei-Feng Lin; Chia-Jen Yang; Chen-Yaw Chiu; Chih-Jung Chang; Chuan-Sheng Lin; Tsung-Ru Wu; Chia-Chen Lu; David Marcelo Ojcius; Hsin-Chih Lai; Ding-E Young
- Web page: https://patentgrep.com/patent/US20160354405A1

## CPC

- A61K 31/715: Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K 36/074: Ganoderma
- A61P 3/08: for glucose homeostasis (pancreatic hormones A61P5/48)
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- A61P 5/50: for increasing or potentiating the activity of insulin
- C08B 37/0003: {General processes for their isolation or fractionation, e.g. purification or extraction from biomass}
- A61K 2236/00: Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C08B: POLYSACCHARIDES; DERIVATIVES THEREOF (polysaccharides containing less than six saccharide radicals attached to each other by glycosidic linkages C07H; fermentation or enzyme-using processes C12P19/00; sugar industry C13; production of cellulose D21)

## Abstract

The present invention provides a method to prepare polysaccharides from Ganoderma lucidum. The prepared polysaccharides can reduce hyperglycemia and improve insulin sensitivity in humans and animals, and can therefore be used to prevent and treat type 2 diabetes.

## Claims

### Claim 1

A method for improving insulin sensitivity, comprising administrating an effective amount of a polysaccharide isolated from Ganoderma lucidum to a subject, wherein the polysaccharide has a molecular weight above 135 kDa and contains at least mannose, glucose, and galactose.

### Claim 2 (depends on 1)

The method of claim 1, wherein the polysaccharide further contains fucose, rhamnose, arabinose, and glucosamine.

### Claim 3 (depends on 2)

The method of claim 2, wherein a weight ratio of fucose, rhamnose, arabinose, glucosamine, galactose, glucose, and mannose in the polysaccharide ranges between 2:2:2:1:16:26:47 and 3:3:3:1:17:27:48.

### Claim 4 (depends on 1)

The method of claim 1, wherein the molecular weight of the polysaccharide ranges from 135 kDa to 5,364 kDa, with a polydispersity index (Mw/Mn) of 6.25.

### Claim 5 (depends on 1)

The method of claim 1, wherein the average molecular weight of the polysaccharide is 846 kDa.

### Claim 6 (depends on 1)

The method of claim 1, wherein the polysaccharide reduces fasting blood insulin and fasting blood glucose in a subject.

### Claim 7 (depends on 1)

The method of claim 1, wherein the polysaccharide reduces insulin resistance in a subject.

### Claim 8 (depends on 1)

The method of claim 1, wherein the effective amount of the polysaccharide given is from 0.001 mg/kg to 1 g/kg per day.

### Claim 9 (depends on 1)

The method of claim 1, wherein the effective amount of the polysaccharide is 0.0646 g per kilogram of body weight.

### Claim 10 (depends on 1)

A method to prepare the polysaccharide of claim 1, comprising the following steps:
extracting G. lucidum mycelium with water;
inducing the formation of a precipitate by adding an alcohol;
isolating the precipitate by centrifugation; and
fractionating the precipitate by filtration,
wherein, (a) mixing the G. lucidum mycelium with water to give a first mixture, extracting the first mixture for a first predetermined time under a low-speed rotation to give a supernatant, and concentrating the supernatant to obtain a concentrated G. lucidum extract;
(b) adding an alcohol to the concentrated G. lucidum extract to give a second mixture, allowing the second mixture to stand for a second predetermined time and produce a precipitate to obtain a crude G. lucidum polysaccharide extract; and
(c) isolating the crude G. lucidum polysaccharide extract with centrifugation, and fractionating the crude polysaccharide extract using tangential flow filtration (TFF) to obtain a G. lucidum polysaccharide.

### Claim 11 (depends on 10)

The method of claim 10, wherein the supernatant of step (a) is concentrated using a vacuum concentrator.

### Claim 12 (depends on 10)

The method of claim 10, wherein, for step (a), the G. lucidum mycelium is mixed with water at a ratio of 5% (w/v).

### Claim 13 (depends on 10)

The method of claim 10, wherein the alcohol used in step (b) comprises 95% ethanol.

### Claim 14 (depends on 13)

The method of claim 13, wherein, for step (b), each volume of the concentrated G. lucidum water extract is mixed with 5 volumes of 95% ethanol.

### Claim 15 (depends on 10)

The method of claim 10, wherein the second predetermined time of step (b) is at least 16 hours.

### Claim 16 (depends on 10)

The method of claim 10, wherein step (c) comprises fractionating the crude G. lucidum polysaccharide extract using tangential flow filtration with a 0.2-μm hollow fiber membrane and a 10 to 300-kDa cassette membrane (50 cm2, PES).
